23
Last reporting period 30 Jun, 2023
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.216
Exchange
XHKG - Hong Kong Exchange
17.076
Last period CFO / Debt ratio ,CNY
106%
CFO / Debt ratio has increased in 5 years
What is CFO / Debt ratio ?
CFO / Debt ratio is the ability of a company to pay off all of its debt obligations with cash generated from operating activities. The value 1 is the benchmark for Eyestock Rating calculation.
See also Dawnrays Pharmaceutical
Company Analysis
2348.HK valuation, rating, competitors, insights and company profile
Eyestock Rating
2348.HK financial analysis by Eyestock methodology
Valuation
2348.HK valuation using historical relative method
Statements
2348.HK Income Statements, Balance Sheet and Cash Flow Statements
Dividends
2348.HK dividend yield and annual dividend
CFO / Debt ratio is the ability of a company to pay off all of its debt obligations with cash generated from operating activities. The value 1 is the benchmark for Eyestock Rating calculation.
Dawnrays Pharmaceutical`s CFO / Debt ratio for the last twelve months ended 2023-06-30 is 17.076
